Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir
Open Access
- 16 September 2021
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 9 (9), 1230
- https://doi.org/10.3390/biomedicines9091230
Abstract
The coronavirus disease 2019 (COVID-19) pandemic severely impacts health, economy, and society worldwide. Antiviral drugs against SARS-CoV-2 are urgently needed to cope with this global crisis. It has been found that the biogenesis and release mechanisms of viruses share a common pathway with extracellular vesicles (EVs). We hypothesized that small molecule inhibitors of EV biogenesis/release could exert an anti-SARS-CoV-2 effect. Here, we screened 17 existing EV inhibitors and found that calpeptin, a cysteine proteinase inhibitor, exhibited the most potent anti-SARS-CoV-2 activity with no apparent cytotoxicity. Calpeptin demonstrated the dose-dependent inhibition against SARS-CoV-2 viral nucleoprotein expression in the infected cells with a half-maximal inhibitory concentration (IC50) of 1.44 µM in Vero-E6 and 26.92 µM in Calu-3 cells, respectively. Moreover, calpeptin inhibited the production of infectious virions with the lower IC50 of 0.6 µM in Vero E6 cells and 10.12 µM in Calu-3 cells. Interestingly, a combination of calpeptin and remdesivir, the FDA-approved antiviral drug against SARS-CoV-2 viral replication, significantly enhanced the anti-SARS-CoV-2 effects compared to monotherapy. This study discovered calpeptin as a promising candidate for anti-SARS-CoV-2 drug development. Further preclinical and clinical studies are warranted to elucidate the therapeutic efficacy of calpeptin and remdesivir combination in COVID-19.Funding Information
- Office of National Higher Education Science Research and Innovation Policy Council (PMU-B), Thailand (B17F640004)
This publication has 49 references indexed in Scilit:
- Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivoScientific Reports, 2015
- Coronavirus and Influenza Virus Proteolytic Priming Takes Place in Tetraspanin-Enriched Membrane MicrodomainsJournal of Virology, 2015
- Prion protein fragment (106–126) induces prothrombotic state by raising platelet intracellular calcium and microparticle releaseCell Calcium, 2015
- The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell LineDNA Research, 2014
- Microvesicle Shedding and Lysosomal Repair Fulfill Divergent Cellular Needs during the Repair of Streptolysin O-Induced Plasmalemmal DamagePLOS ONE, 2014
- Lateral organization of membrane proteins: tetraspanins spin their webBiochemical Journal, 2009
- Severe Acute Respiratory Syndrome Coronavirus Evades Antiviral Signaling: Role of nsp1 and Rational Design of an Attenuated StrainJournal of Virology, 2007
- Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and β-D-N4-HydroxycytidineAntiviral Chemistry and Chemotherapy, 2004
- Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 BuddingCell, 2001
- Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injuryGastroenterology, 1996